5 reports

  • DRUG OVERDOSE - PIPELINE BY FAB'ENTECH SA, H2 2018
  • DRUG OVERDOSE - PIPELINE BY CROSSJECT SA, H2 2018

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ##, ##, ## and ## respectively.

  • Anesthetics
  • Opioid
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • DRUG OVERDOSE - PIPELINE BY CROSSJECT SA, H1 2018
  • DRUG OVERDOSE - PIPELINE BY ADAPT PHARMA LTD, H1 2018

The molecules developed by Companies in Pre-Registration, Phase I, IND/ CTA Filed, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Opioid
  • Pharmaceutical
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY CAMURUS AB, H2 2018
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY BIODELIVERY SCIENCES INTERNATIONAL INC, H2 2018

It acts by targeting both casein kinase ## delta (CK## delta) and casein kinase ## epsilon (CK## epsilon).

  • Opioid
  • United States
  • Company
  • Product Initiative
  • Addex Therapeutics Ltd
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY CAMURUS AB, H1 2018
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY FAB'ENTECH SA, H1 2018

## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIU

  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pharmaceutical
  • World